Evidence map›Paper›PMID 22990306›Full record

ArticleGut2013

Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.

Dominique S Michaud, Jacques Izard, Charlotte S Wilhelm-Benartzi, Doo-Ho You, Verena A Grote, Anne Tjønneland, Christina C Dahm, Kim Overvad, Mazda Jenab, Veronika Fedirko and 33 more

Registry-linked trialAbstract read
In one paragraph

Article in Gut, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04993846 (Pancreatic canceR pErioDontAl sTatus and Oral micRobiome - PREDATOR Study), which is not on this map. Cited by 271 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 3 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04993846 unknown statusnot on this mapstarted 2021, after this paper: background citation

Pancreatic canceR pErioDontAl sTatus and Oral micRobiome - PREDATOR Study

TypeobservationalSponsorAzienda Ospedaliera Universitaria Integrata VeronaRan2021 to 2023Enrolled120ConditionsOral Microbiome, Pancreatic Cancer, IPMN, ParodontopathyArmsDental plaque sampling, qPCR
3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 3 syntheses or guidelines pooled it, 404 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 11 countries.

Dominique S MichaudDepartment of Epidemiology, Division of Biology and Medicine, Brown University, Providence, Rhode Island, USA.
Jacques Izard
Charlotte S Wilhelm-Benartzi
Doo-Ho You
Verena A Grote
Anne Tjønneland
Christina C Dahm
Kim Overvad
Mazda Jenab
Veronika Fedirko
Marie Christine Boutron-Ruault
Françoise Clavel-Chapelon
Antoine Racine
Rudolf Kaaks
Heiner Boeing
Jana Foerster
Antonia Trichopoulou
Pagona Lagiou
Dimitrios Trichopoulos
Carlotta Sacerdote
Sabina Sieri
Domenico Palli
Rosario Tumino
Salvatore Panico
Peter D Siersema
Petra H M Peeters
Eiliv Lund
Aurelio Barricarte
José-María Huerta
Esther Molina-Montes
Miren Dorronsoro
J Ramón Quirós
Eric J Duell
Weimin Ye
Malin Sund
Björn Lindkvist
Dorthe Johansen
Kay-Tee Khaw
Nick Wareham
Ruth C Travis
Paolo Vineis
H Bas Bueno-de-Mesquita
Elio Riboli
Imperial College London · GBAarhus University · DKAgència de Salut Pública de Catalunya · ESCentre International de Recherche sur le Cancer · FRGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEHarvard University · USInserm · FRPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity Medical Center Utrecht · NLAcademy of Athens · GRAzienda Usl 8 Arezzo · ITBasque Government · ESBrown University · USCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITHellenic Health Foundation · GRInstitut Català d'Oncologia · ES

Funding

SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISKR21CA139193 · NCI · BROWN UNIVERSITY · PI IZARD, JACQUES G., MICHAUD, DOMINIQUE S. · 2010 to 2011
$439k
Cancer Research UK 15954Cancer Research UK A11692Cancer Research UK C864/A8257Medical Research Council D74922Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_U106179471Medical Research Council MC_UU_12015/1NCI NIH HHS R21 CA139193Wellcome Trust
6 · The paper itself

Abstract

objectiveExamine the relationship between antibodies to 25 oral bacteria and pancreatic cancer risk in a prospective cohort study.

designWe measured antibodies to oral bacteria in prediagnosis blood samples from 405 pancreatic cancer cases and 416 matched controls, nested within the European Prospective Investigation into Cancer and Nutrition study. Analyses were conducted using conditional logistic regression and additionally adjusted for smoking status and body mass index.

resultsIndividuals with high levels of antibodies against Porphyromonas gingivalis ATTC 53978, a pathogenic periodontal bacteria, had a twofold higher risk of pancreatic cancer than individuals with lower levels of these antibodies (OR 2.14; 95% CI 1.05 to 4.36; >200 ng/ml vs ≤200 ng/ml). To explore the association with commensal (non-pathogenic) oral bacteria, we performed a cluster analysis and identified two groups of individuals, based on their antibody profiles. A cluster with overall higher levels of antibodies had a 45% lower risk of pancreatic cancer than a cluster with overall lower levels of antibodies (OR 0.55; 95% CI 0.36 to 0.83).

conclusionsPeriodontal disease might increase the risk for pancreatic cancer. Moreover, increased levels of antibodies against specific commensal oral bacteria, which can inhibit growth of pathogenic bacteria, might reduce the risk of pancreatic cancer. Studies are needed to determine whether oral bacteria have direct effects on pancreatic cancer pathogenesis or serve as markers of the immune response.

Indexed as

AdultAgedAntibodies, BacterialCase-Control StudiesFemaleHumansMaleMiddle AgedPancreatic NeoplasmsPeriodontal DiseasesPorphyromonas gingivalisRisk FactorsVeillonellaAntibodies, BacterialBacterial PathogenesisEpidemiologyPancreatic Cancer

Identifiers

PMID22990306
PMCPMC3815505
OpenAlexW2076219872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.